NCT02192866
- Conditions
- Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- University of Colorado School of Medicine Denver, Colorado, United States
Clinical trial condition
Hypersensitivity
Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.
6,730 public trials
637 recruiting studies
Hypersensitivity trial results
NCT03659227
- Conditions
- AGEP, Bullous Dermatosis Caused by Drug Treatment (Disorder), Chemically-Induced Disorders, +24 more
- Locations
-
- Henri Mondor Créteil, France
Recruiting
Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis
NCT05348148
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +11 more
- Locations
-
- Camillian Saint Mary's Hospital Luodong Luodong, Yilan, Taiwan
Recruiting
CLOUD-R HAE REGISTRY
NCT03845946
- Conditions
- Angioedema, Cardiovascular Diseases, Hypersensitivity, +7 more
- Locations
-
- University Hospital Grenoble Grenoble, Isere, France
Recruiting
Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
NCT02947945
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- National Jewish Health Denver, Colorado, United States
Recruiting
Controls for Respiratory Diseases
NCT03120481
- Conditions
- Actinomycetales Infections, Asthma, Bacterial Infections, +30 more
- Locations
-
- Seoul National University Healthcare System Gangnam Center Seoul, South Korea
Recruiting
Seoul National University Airway Registry
NCT02527486
- Conditions
- Asthma, Asthma With Chronic Obstructive Pulmonary Disease, Bronchial Diseases, +16 more
- Locations
-
- Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
- Seoul National University Hospital Seoul, South Korea
- Seoul Metropolitan Government-Seoul National University Boramae Medical Center Seoul, South Korea
Enrolling by Invitation
A Long-Term Study of Navenibart in Participants With Hereditary Angioedema
NCT07204938
- Conditions
- Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
- Locations
-
- Site 2 Scottsdale, Arizona, United States
- Site 3 Little Rock, Arkansas, United States
- Site 7 San Diego, California, United States
- Site 4 Santa Monica, California, United States
Enrolling by Invitation
An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
NCT06169397
- Conditions
- Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
- Locations
-
- Xentria Investigative Site Denver, Colorado, United States
- Xentria Investigative Site Chicago, Illinois, United States
- Xentria Investigative Site Greenville, North Carolina, United States
- Xentria Investigative Site Cincinnati, Ohio, United States
Enrolling by Invitation
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
NCT05735483
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- Clinical Research Center of Alabama Birmingham, Alabama, United States
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Arkansas Research Trials North Little Rock, Arkansas, United States
- First OC Dermatology Fountain Valley, California, United States